Koers Alexion Pharmaceuticals, Inc.
Aandelen
ALXN
US0153511094
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01-08-21 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,79% | 676 mld. | |
+23,98% | 554 mld. | |
-7,64% | 349 mld. | |
+15,00% | 318 mld. | |
+5,99% | 291 mld. | |
+3,09% | 210 mld. | |
-0,31% | 204 mld. | |
-9,53% | 194 mld. | |
-11,71% | 144 mld. |